MASIMO CORP (MASI) Stock Fundamental Analysis
USA - NASDAQ:MASI - US5747951003 - Common Stock
147.78 USD
-0.95 (-0.64%)
147.78 USD
0 (0%)
Overall MASI gets a fundamental rating of 4 out of 10. We evaluated MASI against 190 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of MASI get a neutral evaluation. Nothing too spectacular is happening here. MASI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
MASI had positive earnings in the past year.
MASI had a positive operating cash flow in the past year.
Of the past 5 years MASI 4 years were profitable.
MASI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -19.11%, MASI perfoms like the industry average, outperforming 51.05% of the companies in the same industry.
With a Return On Equity value of -44.04%, MASI perfoms like the industry average, outperforming 51.58% of the companies in the same industry.
MASI has a better Return On Invested Capital (5.36%) than 78.42% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MASI is below the industry average of 8.88%.
The last Return On Invested Capital (5.36%) for MASI is above the 3 year average (4.63%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.11% | ||
| ROE | -44.04% | ||
| ROIC | 5.36% |
ROA(3y)-1.49%
ROA(5y)4.35%
ROE(3y)-4.1%
ROE(5y)3.92%
ROIC(3y)4.63%
ROIC(5y)8.2%
1.3 Margins
The Operating Margin of MASI (6.64%) is better than 73.16% of its industry peers.
MASI's Operating Margin has declined in the last couple of years.
The Gross Margin of MASI (52.76%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MASI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.64% | ||
| PM (TTM) | N/A | ||
| GM | 52.76% |
OM growth 3Y-54.54%
OM growth 5Y-38.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.74%
GM growth 5Y-6.5%
2. Health
2.1 Basic Checks
MASI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MASI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MASI remains at a similar level compared to 5 years ago.
The debt/assets ratio for MASI has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 5.64 indicates that MASI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.64, MASI belongs to the top of the industry, outperforming 80.53% of the companies in the same industry.
MASI has a debt to FCF ratio of 4.14. This is a neutral value as MASI would need 4.14 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.14, MASI belongs to the top of the industry, outperforming 81.58% of the companies in the same industry.
MASI has a Debt/Equity ratio of 0.57. This is a neutral value indicating MASI is somewhat dependend on debt financing.
MASI has a worse Debt to Equity ratio (0.57) than 64.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 4.14 | ||
| Altman-Z | 5.64 |
ROIC/WACC0.66
WACC8.18%
2.3 Liquidity
A Current Ratio of 2.14 indicates that MASI has no problem at all paying its short term obligations.
With a Current ratio value of 2.14, MASI is not doing good in the industry: 60.53% of the companies in the same industry are doing better.
A Quick Ratio of 1.61 indicates that MASI should not have too much problems paying its short term obligations.
MASI has a Quick ratio of 1.61. This is comparable to the rest of the industry: MASI outperforms 43.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.14 | ||
| Quick Ratio | 1.61 |
3. Growth
3.1 Past
MASI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.84%, which is quite impressive.
The Earnings Per Share has been growing slightly by 5.86% on average over the past years.
Looking at the last year, MASI shows a decrease in Revenue. The Revenue has decreased by -8.36% in the last year.
MASI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.43% yearly.
EPS 1Y (TTM)60.84%
EPS 3Y2.37%
EPS 5Y5.86%
EPS Q2Q%54.65%
Revenue 1Y (TTM)-8.36%
Revenue growth 3Y19.12%
Revenue growth 5Y17.43%
Sales Q2Q%-25.27%
3.2 Future
Based on estimates for the next years, MASI will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.14% on average per year.
MASI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.12% yearly.
EPS Next Y27%
EPS Next 2Y17.47%
EPS Next 3Y15.6%
EPS Next 5Y12.14%
Revenue Next Year-27.11%
Revenue Next 2Y-11.36%
Revenue Next 3Y-5.25%
Revenue Next 5Y-0.12%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 27.67 indicates a quite expensive valuation of MASI.
MASI's Price/Earnings ratio is a bit cheaper when compared to the industry. MASI is cheaper than 75.26% of the companies in the same industry.
MASI is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 25.02 indicates a quite expensive valuation of MASI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MASI indicates a somewhat cheap valuation: MASI is cheaper than 75.26% of the companies listed in the same industry.
MASI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.92, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.67 | ||
| Fwd PE | 25.02 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, MASI is valued a bit cheaper than 68.42% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MASI is valued a bit cheaper than the industry average as 75.79% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 54.09 | ||
| EV/EBITDA | 43.9 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as MASI's earnings are expected to grow with 15.60% in the coming years.
PEG (NY)1.02
PEG (5Y)4.73
EPS Next 2Y17.47%
EPS Next 3Y15.6%
5. Dividend
5.1 Amount
MASI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
147.78
-0.95 (-0.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners107.26%
Inst Owner Change-0.08%
Ins Owners0.18%
Ins Owner Change2%
Market Cap8.03B
Revenue(TTM)1.85B
Net Income(TTM)-459200000
Analysts82.67
Price Target190.86 (29.15%)
Short Float %7.28%
Short Ratio5.06
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.44%
Min EPS beat(2)6.64%
Max EPS beat(2)10.25%
EPS beat(4)4
Avg EPS beat(4)11.67%
Min EPS beat(4)6.64%
Max EPS beat(4)14.9%
EPS beat(8)8
Avg EPS beat(8)11.28%
EPS beat(12)12
Avg EPS beat(12)9.75%
EPS beat(16)16
Avg EPS beat(16)8.76%
Revenue beat(2)0
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-1.35%
Max Revenue beat(2)-0.77%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.58%
Max Revenue beat(4)-0.59%
Revenue beat(8)0
Avg Revenue beat(8)-1.74%
Revenue beat(12)2
Avg Revenue beat(12)-1.66%
Revenue beat(16)5
Avg Revenue beat(16)-1.07%
PT rev (1m)0%
PT rev (3m)1.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.07%
EPS NY rev (1m)0%
EPS NY rev (3m)7.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.67 | ||
| Fwd PE | 25.02 | ||
| P/S | 4.34 | ||
| P/FCF | 54.09 | ||
| P/OCF | 45.46 | ||
| P/B | 7.7 | ||
| P/tB | 9.08 | ||
| EV/EBITDA | 43.9 |
EPS(TTM)5.34
EY3.61%
EPS(NY)5.91
Fwd EY4%
FCF(TTM)2.73
FCFY1.85%
OCF(TTM)3.25
OCFY2.2%
SpS34.02
BVpS19.2
TBVpS16.28
PEG (NY)1.02
PEG (5Y)4.73
Graham Number48.03
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.11% | ||
| ROE | -44.04% | ||
| ROCE | 6.78% | ||
| ROIC | 5.36% | ||
| ROICexc | 5.84% | ||
| ROICexgc | 6.46% | ||
| OM | 6.64% | ||
| PM (TTM) | N/A | ||
| GM | 52.76% | ||
| FCFM | 8.03% |
ROA(3y)-1.49%
ROA(5y)4.35%
ROE(3y)-4.1%
ROE(5y)3.92%
ROIC(3y)4.63%
ROIC(5y)8.2%
ROICexc(3y)5.01%
ROICexc(5y)12.81%
ROICexgc(3y)9.36%
ROICexgc(5y)17.94%
ROCE(3y)5.86%
ROCE(5y)10.38%
ROICexgc growth 3Y-54.41%
ROICexgc growth 5Y-39.37%
ROICexc growth 3Y-57.67%
ROICexc growth 5Y-43.42%
OM growth 3Y-54.54%
OM growth 5Y-38.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.74%
GM growth 5Y-6.5%
F-Score6
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 4.14 | ||
| Debt/EBITDA | 3.08 | ||
| Cap/Depr | 39.28% | ||
| Cap/Sales | 1.53% | ||
| Interest Coverage | 3.71 | ||
| Cash Conversion | 90.75% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.14 | ||
| Quick Ratio | 1.61 | ||
| Altman-Z | 5.64 |
F-Score6
WACC8.18%
ROIC/WACC0.66
Cap/Depr(3y)60.07%
Cap/Depr(5y)110.25%
Cap/Sales(3y)3.16%
Cap/Sales(5y)3.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.84%
EPS 3Y2.37%
EPS 5Y5.86%
EPS Q2Q%54.65%
EPS Next Y27%
EPS Next 2Y17.47%
EPS Next 3Y15.6%
EPS Next 5Y12.14%
Revenue 1Y (TTM)-8.36%
Revenue growth 3Y19.12%
Revenue growth 5Y17.43%
Sales Q2Q%-25.27%
Revenue Next Year-27.11%
Revenue Next 2Y-11.36%
Revenue Next 3Y-5.25%
Revenue Next 5Y-0.12%
EBIT growth 1Y-24.75%
EBIT growth 3Y-45.85%
EBIT growth 5Y-27.67%
EBIT Next Year42.43%
EBIT Next 3Y17.05%
EBIT Next 5Y13.83%
FCF growth 1Y624.38%
FCF growth 3Y-14.18%
FCF growth 5Y-0.52%
OCF growth 1Y535.25%
OCF growth 3Y-9.48%
OCF growth 5Y-2.39%
MASIMO CORP / MASI FAQ
What is the fundamental rating for MASI stock?
ChartMill assigns a fundamental rating of 4 / 10 to MASI.
What is the valuation status for MASI stock?
ChartMill assigns a valuation rating of 4 / 10 to MASIMO CORP (MASI). This can be considered as Fairly Valued.
Can you provide the profitability details for MASIMO CORP?
MASIMO CORP (MASI) has a profitability rating of 4 / 10.
What is the financial health of MASIMO CORP (MASI) stock?
The financial health rating of MASIMO CORP (MASI) is 6 / 10.
How sustainable is the dividend of MASIMO CORP (MASI) stock?
The dividend rating of MASIMO CORP (MASI) is 0 / 10 and the dividend payout ratio is 0%.